Scholarlink

Background <p>Non-IgE mediated cow’s milk protein allergy (CMPA) is being increasingly recognized in infants. Tumor necrosis factor alpha (TNF-α) is a cytokine that has been identified as a key modulator of inflammatory responses and is implicated in the pathogenesis of some inflammatory and autoimmune diseases. The influence of immune mechanisms in the pathogenesis of non-IgE mediated CMPA during infancy remains to be clarified.</p> Objectives <p>This study aims to evaluate the role of the gut TNF-α in the susceptibility to non-IgE mediated cow’s milk protein allergy in infants.</p> Methods <p>A case-control study consisted of 88 infants, aged 1–12 months; of these, 60 had challenge-proven non-IgE mediated CMPA appeared as either delayed onset gastrointestinal, skin, and/or respiratory symptoms. Twenty-eight healthy age- and sex-matched infants were studied as controls. TNF-α in the stool of infants was measured by ELISA.</p> Results <p>Gastroesophageal reflux was the most common gastrointestinal symptom (55%) of patients.</p> <p>Cow's Milk related Symptom Score (CoMiSS) was significant between patients and control at <i>p</i>=0.001. The median fecal TNF-α levels were significantly lower in non-IgE mediated CMPA infants compared to control [52 (IQR 11.9-156) pg/mL and 156 (IQR 41-217.7) pg/mL respectively] at <i>p</i>=0.02. At a cutoff threshold of 128 pg/mL, infants with TNF-α levels below this threshold had higher odds of being in the CMPA group ( OR= 2.6; (95% Cl: 1.1-6.6).</p> Conclusions <p>Gastroesophageal reflux is the most common gastrointestinal symptom in non-IgE mediated CMPA. Limited TNF-α production in the gut could contribute to vulnerability to gut inflammation. These results may help to clarify the etiopathology of non-IgE mediated CMPA and explain the rate of tolerance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of fecal tumor necrosis factor alpha (TNF-α) in infants with non-IgE mediated cow’s milk protein allergy: a case-control study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月1日

查看全文
  • Nehal Abdelhamid,
  • Hanan M Hamed,
  • Yomna A Moniem,
  • Hani A Elmikaty,
  • Sally Hafez,
  • Amal Mohyeldeen

摘要

Background

Non-IgE mediated cow’s milk protein allergy (CMPA) is being increasingly recognized in infants. Tumor necrosis factor alpha (TNF-α) is a cytokine that has been identified as a key modulator of inflammatory responses and is implicated in the pathogenesis of some inflammatory and autoimmune diseases. The influence of immune mechanisms in the pathogenesis of non-IgE mediated CMPA during infancy remains to be clarified.

Objectives

This study aims to evaluate the role of the gut TNF-α in the susceptibility to non-IgE mediated cow’s milk protein allergy in infants.

Methods

A case-control study consisted of 88 infants, aged 1–12 months; of these, 60 had challenge-proven non-IgE mediated CMPA appeared as either delayed onset gastrointestinal, skin, and/or respiratory symptoms. Twenty-eight healthy age- and sex-matched infants were studied as controls. TNF-α in the stool of infants was measured by ELISA.

Results

Gastroesophageal reflux was the most common gastrointestinal symptom (55%) of patients.

Cow's Milk related Symptom Score (CoMiSS) was significant between patients and control at p=0.001. The median fecal TNF-α levels were significantly lower in non-IgE mediated CMPA infants compared to control [52 (IQR 11.9-156) pg/mL and 156 (IQR 41-217.7) pg/mL respectively] at p=0.02. At a cutoff threshold of 128 pg/mL, infants with TNF-α levels below this threshold had higher odds of being in the CMPA group ( OR= 2.6; (95% Cl: 1.1-6.6).

Conclusions

Gastroesophageal reflux is the most common gastrointestinal symptom in non-IgE mediated CMPA. Limited TNF-α production in the gut could contribute to vulnerability to gut inflammation. These results may help to clarify the etiopathology of non-IgE mediated CMPA and explain the rate of tolerance.